What happened

PMA Graphene Technology Group Inc. (NASDAQ: PMA) agreed to buy Lanchuang Technology Limited for $260 million, all in securities. The stock purchase agreement is dated Nov. 18. PMA owes no cash at closing.

At closing PMA will issue 62.5 million Class A ordinary shares, worth $81.25 million at an agreed reference price of $1.30 each. It will also issue unsecured convertible notes with $178.75 million of principal. The sellers split both in proportion to their stakes in Lanchuang.

What Lanchuang does

Through a wholly owned Hong Kong subsidiary, Lanchuang develops and provides Internet of Things sensors and monitoring terminals, artificial intelligence algorithm models and cloud service platform solutions. Customers use them for ecological, environmental and production safety monitoring. They include government regulators and industrial enterprises.

PMA says the sellers and Lanchuang supplied that description and that PMA has not independently verified it. The agreement says Lanchuang was incorporated in the British Virgin Islands on July 2, 2026.

How the notes work

The notes pay no interest and have no fixed maturity date. They rank equally with PMA's other unsecured, unsubordinated obligations. They convert into Class A shares at the same fixed price as the share issue.

Principal is split into three equal annual tranches of $59.58 million. Each ties to one of three consecutive twelve-month performance years that start at closing. A tranche becomes eligible for conversion only if Lanchuang's net profit after tax for that year reaches an agreed minimum. The threshold is set by reference to its financial forecast, as determined by PMA. PMA must also issue a written eligibility notice.

A later year's tranche cannot be pulled forward. Once a tranche is eligible, its unconverted balance stays available for conversion. The agreement's note schedule lists Lanchuang Holdings Limited at $91.16 million of the principal, in three installments of $30.39 million.

Why it matters

OptimistFi has argued that PMA's outlook turns on its balance sheet. A purchase with no cash at closing and interest-free notes does not draw on PMA's cash, which fits that view.

Holders pay in dilution instead. The 62.5 million shares are issued at closing whatever Lanchuang earns. Only the notes carry profit conditions. By OptimistFi's calculation the notes are 68.8% of the price, so most of the consideration can become shares only if Lanchuang meets its profit tests.

The deal also adds a sensor and monitoring business and issues new shares at closing, so OptimistFi sees the effect on its case as mixed.

PMA also says it follows Cayman Islands home country practice instead of Nasdaq shareholder approval rules 5635(a), 5635(b) and 5635(d). So it has not called a general meeting to approve the deal. The shares and notes are issued outside the United States under Regulation S. They carry restrictive legends and a one-year distribution compliance period.

The filing states the caveats itself. PMA has not independently verified the information on Lanchuang. It gives no assurance that the deal will complete or complete on time. It also says the agreed share price is a contractual reference, not a statement of fair value.

Explain the financial terms

A balance sheet shows a company's assets, debts and owners' equity at a point in time.

What's next

Closing is scheduled for Dec. 15, 2026, or another date PMA and the sellers agree in writing. It depends on two things. PMA must finish due diligence to its reasonable satisfaction. Its Listing of Additional Shares notification must also reach Nasdaq without objection within the notice period.

If the deal has not closed by March 31, 2027, either PMA or the sellers may terminate. A Dec. 15 closing would start the first twelve-month performance year. The first test of the notes is whether Lanchuang's net profit for that year reaches the agreed threshold.

Sources checked automatically Nov 18, 2026 · Human review: none
Thesis impactPMA: no published thesis yet.